Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT

Status

Terminated

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01273285

Enrollment

Registered

2011-01-10

Start date

2009-04-30

Completion date

Unknown

Last updated

2011-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Patients and Healthy Controls

Brief summary

To assess the reproducibility of Spectral-Domain-OCT (SD-OCT) retinal nerve fiber layer thickness (RNFL) thickness measurements in healthy volunteers and patients with glaucoma and to compare these results to conventional Time-Domain-OCT (TD-OCT). * Trial with medical device

Interventions

DEVICESpectralis® SD-OCT, Heidelberg Engineering GmbH, H

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

control group: age 18yo or older, healthy glaucom group: age 18yo or older, diagnosis of primary open angle glaucoma (POAG)

Design outcomes

Primary

Measure	Time frame
reproducibility of retinal nerve fiber layer thickness measurement	—

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026